Atreca Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Atreca Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11203
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Atreca Inc (Atreca) is a biotechnology company that develops and develops novel therapies based on the human immune response. The company develops proprietary immune repertoire capture technology that act as an engine for the discovery and development of antibody based therapeutics, diagnostics, vaccines and research reagents. Its technology has partnerships with pharmaceutical companies, academic institutions, non-profit foundations and governmental entities. Its pipeline products are intended for the treatment of breast tumor, lung tumor, colon tumor and other solid tumors. Atreca is headquartered in Redwood City, California, the US.

Atreca Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Atreca Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Atreca Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Atreca Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Atreca Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Atreca Inc, Medical Devices Deals, 2012 to YTD 2018 9
Atreca Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Atreca Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Atreca Raises USD125 Million in Series C Venture Financing 12
Atreca Raises USD35 Million in Series B Financing 14
Atreca Raises USD56 Million in Series A Financing 15
Atreca Raises USD57.26 Million in Venture Financing 16
Atreca Raises USD0.7 Million in Venture Financing 17
Atreca Raises USD0.05 Million in Venture Financing 18
Atreca Raises USD3 Million in Venture Financing 19
Atreca Raises Funds through Venture Financing 20
Atreca Raises USD0.4 Million in Venture Financing 21
Partnerships 22
Atreca and Dana-Farber Cancer Institute Enter into R&D Agreement 22
Atreca Enters into Agreement with Genome Institute of Singapore 23
Atreca Enters into Research Agreement with Janssen Biotech 24
Atreca Enters into Agreement with Bill & Melinda Gates Foundation 25
Licensing Agreements 26
Atreca Enters Into Licensing Agreement With Stanford University For Immune Repertoire Capture Technology 26
Atreca Inc – Key Competitors 27
Atreca Inc – Key Employees 28
Atreca Inc – Locations And Subsidiaries 29
Head Office 29
Recent Developments 30
Corporate Communications 30
Apr 19, 2018: Atreca Names John A. Orwin As President and CEO 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Atreca Inc, Pharmaceuticals & Healthcare, Key Facts 2
Atreca Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Atreca Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Atreca Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Atreca Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Atreca Inc, Medical Devices Deals, 2012 to YTD 2018 9
Atreca Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Atreca Raises USD125 Million in Series C Venture Financing 12
Atreca Raises USD35 Million in Series B Financing 14
Atreca Raises USD56 Million in Series A Financing 15
Atreca Raises USD57.26 Million in Venture Financing 16
Atreca Raises USD0.7 Million in Venture Financing 17
Atreca Raises USD0.05 Million in Venture Financing 18
Atreca Raises USD3 Million in Venture Financing 19
Atreca Raises Funds through Venture Financing 20
Atreca Raises USD0.4 Million in Venture Financing 21
Atreca and Dana-Farber Cancer Institute Enter into R&D Agreement 22
Atreca Enters into Agreement with Genome Institute of Singapore 23
Atreca Enters into Research Agreement with Janssen Biotech 24
Atreca Enters into Agreement with Bill & Melinda Gates Foundation 25
Atreca Enters Into Licensing Agreement With Stanford University For Immune Repertoire Capture Technology 26
Atreca Inc, Key Competitors 27
Atreca Inc, Key Employees 28

List of Figures
Atreca Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Atreca Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Atreca Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Atreca Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Atreca Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Atreca Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Atreca Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Atreca Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Atreca Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Atreca Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Covagen AG-製薬・医療分野:企業M&A・提携分析
    Summary Covagen AG (Covagen), a subsidiary of Cilag GmbH International is a biopharmaceutical company specializing in the development of multispecific protein therapeutics through the FynomAb technology. The company’s pipeline products include COVA 322, a bispecific anti-tumor necrosis factor alpha …
  • Biosensors International Group Ltd:企業の戦略的SWOT分析
    Biosensors International Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Statoil ASA:企業のM&A・事業提携・投資動向
    Statoil ASA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Statoil ASA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Kroton Educacional S.A. (KROT3):企業の財務・戦略的SWOT分析
    Kroton Educacional S.A. (KROT3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • NuVista Energy Ltd (NVA):企業の財務・戦略的SWOT分析
    Summary NuVista Energy Ltd (NuVista) is an oil and gas company that offers exploration, development and production of oil and natural gas reserves. The company conducts its operations in Western Canadian Sedimentary Basin which is located in West Central Alberta and Northeast British Columbia areas …
  • Incyte Corp (INCY):企業の財務・戦略的SWOT分析
    Incyte Corp (INCY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Institute for Translational Vaccinology:製薬・医療:M&Aディール及び事業提携情報
    Summary Institute for Translational Vaccinology (Intravacc) is a nonprofit research and development organization that concentrates on the development of vaccines. The organization’s services include technology transfer, exploratory and clinical research and regulatory support. It also provides novel …
  • GW Pharmaceuticals Plc (GWPH):製薬・医療:M&Aディール及び事業提携情報
    Summary GW Pharmaceuticals Plc (GW Pharmaceuticals) is a biopharmaceutical company that discovers, develops and commercializes novel therapeutics from its proprietary cannabinoid product platform. The company’s commercialized product, Sativex is a plant-derived cannabinoid prescription drug, for the …
  • Egyptian General Petroleum Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary Egyptian General Petroleum Corp (EGPC), formerly General Petroleum Authority, is engaged in the oil and gas exploration services. The company is engaged in the refining, production, drilling, transportation and storage of crude oil; production of lubricants and greases; provides man power su …
  • Saje Pharma LLC-製薬・医療分野:企業M&A・提携分析
    Summary Saje Pharma LLC (Saje Pharma) is a biopharmaceutical company that develops new therapeutic agents for rare and common diseases with unmet medical needs. The company’s lead product candidate includes SPL-334, developed for various indications such as idiopathic pulmonary fibrosis, asthma, inf …
  • Connell Limited Partnership:企業の戦略・SWOT・財務情報
    Connell Limited Partnership - Strategy, SWOT and Corporate Finance Report Summary Connell Limited Partnership - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Lycera Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Lycera Corp (Lycera) is a biopharmaceutical company that focuses on the development of oral immune modulators for the treatment of patients with autoimmune diseases and cancer. The company’s pipeline products include LYC-55716, an oral retinoic acid-related orphan receptor gamma (RORgamma) a …
  • Vision Ease, LP:企業の戦略的SWOT分析
    Vision Ease, LP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • McLane Company Inc:戦略・SWOT・企業財務分析
    McLane Company Inc - Strategy, SWOT and Corporate Finance Report Summary McLane Company Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Akbank TAS (AKBNK):企業の財務・戦略的SWOT分析
    Akbank TAS (AKBNK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Solartron Public Company Limited (SOLAR):企業の財務・戦略的SWOT分析
    Solartron Public Company Limited (SOLAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Orlando Utilities Commission:電力:M&Aディール及び事業提携情報
    Summary Orlando Utilities Commission (OUC) is a municipally-owned public utility that provides water and electric services. The commission generates, transmits, and distributes electricity and water to residential and commercial customers. It also constructs, operates and maintains electric and wate …
  • Mahle GmbH:企業の戦略的SWOT分析
    Mahle GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Victrex plc (VCT):企業の財務・戦略的SWOT分析
    Summary Victrex Plc (Victrex) is a chemical company that manufactures and markets high-performance polymer materials and solutions. The company operates through its business units such as Victrex polymer solutions and Invibio biomaterial solutions. Its Victrex polymer solutions unit serves industria …
  • OPG Power Ventures Plc (OPG):企業の財務・戦略的SWOT分析
    OPG Power Ventures Plc (OPG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆